About the VHIR
Here at the Vall d'Hebron Research Institute (VHIR) we promote biomedical research, innovation and teaching. Over 1,800 people are seeking to understand diseases today so the treatment can be improved tomorrow.
Research
We are working to understand diseases, to find out how they operate and to create better treatments for patients. Get to know about our groups and their lines of research.
People
People are the centre of the Vall d'Hebron Research Institute (VHIR). This is why we are bound by the principles of freedom of research, gender equality and professional attitudes that HRS4R promotes.
Clinical trials
Our work is not just basic or translational; we are leaders in clinical research. Enter and find about the clinical trials we are conducting and why we are a world reference in this field.
Progress
Our aim is to make the research carried out at the Vall d’Hebron Research Institute (VHIR) a driving force for transformation. How? By identifying new channels and solutions for the promotion of people's health and well-being.
Core facilities
We offer specialist support for researchers, internal and external alike, ranging from specific services to preparing complete projects. All this, from a perspective of quality and speed of response.
News
We offer you a gateway for staying up to date on everything going on at the Vall d’Hebron Research Institute (VHIR), from the latest news to future solidarity activities and initiatives that we are organising.
The search for quality and innovation has always been an inherent part of the activity of the Stroke Research Group and represents the common thread that leads us to excellence and continuous improvement.
In recent years, the Stroke Research Group has established itself as a leader in the management, recruitment and international coordination of multicenter clinical trials, as well as in the development of patents for new thrombectomy devices and the creation of new technological solutions and digital platforms to improve the diagnosis, treatment and follow-up of stroke patients. Robust strategic alliances have also been consolidated with public and private entities that ensure the viability and scalability of the research projects initiated in our group.
The Stroke Research Group is made up of a transversal and multidisciplinary team that shares a common idea: to contribute from its area of knowledge to the care and management of stroke through the effective transfer of knowledge and the complementarity of the processes of clinical research.
IP: Mª Ángeles Muchada López Collaborators: Carlos Molina Cateriano, Alvaro Garcia Tornel Garcia Camba, Marc Rodrigo Gisbert Funding agency: Instituto de Salud Carlos III Funding: 123420 Reference: PI22/01928 Duration: 01/01/2023 - 31/12/2025
IP: Jose Fernando Rodríguez Palomares Collaborators: Lydia Dux-Santoy Hurtado, Giorgio Colangelo, Andrea Guala, Javier Solsona Caravaca, Mireia Bragulat Arevalo Funding agency: Ministerio de Asuntos Económicos y Transf Digital Funding: 268649.45 Reference: MIA.2021.M02.0005_R.PALOMARES Duration: 01/01/2021 - 31/12/2024
IP: Marc Ribó Jacobi Collaborators: Pere Canals Canals Funding agency: Generalitat de Catalunya - Departament de Salut Funding: 89148.06 Reference: SLT017/20/000180 Duration: 22/07/2021 - 31/12/2024
IP: Joan Montaner Villalonga Collaborators: Anna Penalba Morenilla, Tamara Del Rio Higueras, Ariadna Martín Balcells, Olalla Pancorbo Rosal, Olga Sánchez- Maroto Carrizo, Amaia Latasa Arrazubi, Daisy Guamán Pilco, Marcel Lamana Vallverdu Funding agency: EUROPEAN COMMISSION Funding: 481723 Reference: PRESTIGE-AF_H2020SC12017 Duration: 01/12/2017 - 30/11/2024
PMID: 37798546 Journal: NEUROLOGICAL SCIENCES Year: 2023 Reference: Neurol Sci. 2023 Oct 6. doi: 10.1007/s10072-023-07089-w. Impact factor: Publication type: Paper in international publication Authors: Forlivesi, Stefano; Galluzzo, Simone; Gentile, Mauro; Logroscino, Giancarlo; Migliaccio, Ludovica; Naldi, Federica; Paolucci, Matteo; Petruzzellis, Marco; Piccolo, Laura; Princiotta, Ciro et al. DOI: 10.1007/s10072-023-07089-w
PMID: 37804071 Journal: EPILEPSIA Year: 2023 Reference: Epilepsia. 2023 Oct 7. doi: 10.1111/epi.17790. Impact factor: Publication type: Letter or abstract Authors: Abraira, Laura; Abraira, Laura; Campos-Fernandez, Daniel; Fonseca, Elena; Fonseca, Elena; Gomez-Dabo, Laura; Lallana, Sofia; Quintana, Manuel; Quintana, Manuel; Rodrigo-Gisbert, Marc et al. DOI: 10.1111/epi.17790
PMID: 37068936 Journal: Journal of NeuroInterventional Surgery Year: 2023 Reference: J Neurointerv Surg. 2023 Apr 17:jnis-2023-020125. doi: 10.1136/jnis-2023-020125. Impact factor: Publication type: Paper in international publication Authors: -Tornel, Alvaro Garcia; Abad, Anna Fontcuberta; Abidi, Khadija El; Abilleira, Sonia; Adell, Vanessa; Agamez, Segovia; Agramunt, Nuria; Aguilo, Oriol; Ajenjo, Monica Prieto; Alaez, Carolina San Juan et al. DOI: 10.1136/jnis-2023-020125
PMID: 37835008 Journal: Journal of Clinical Medicine Year: 2023 Reference: J Clin Med. 2023 Oct 4;12(19):6364. doi: 10.3390/jcm12196364. Impact factor: Publication type: Paper in international publication Authors: Amigo, Judit; Franch-Nadal, Josep; Hernandez, Cristina; Martins, Sheila Cristina Ouriques; Mayor, Regina; Molina, Carlos; Morer, Carla; Nogueira, Raul; Ortiz-Zuniga, Angel; Sanchez, Monica et al. DOI: 10.3390/jcm12196364
PMID: 35281755 Journal: International journal of cardiology. Heart & vasculature Year: 2022 Reference: Int J Cardiol Heart Vasc. 2022 Mar 7;39:100977. doi: 10.1016/j.ijcha.2022.100977. eCollection 2022 Apr. Impact factor: 0 Publication type: Paper in international publication Authors: Pala, Elena, Pagola, Jorge, Juega, Jesus, Francisco-Pascual, Jaume, Penalba, Anna, Rodriguez, Maite, De Lera Alfonso, Mercedes, Arenillas, Juan F, Cabezas, Juan Antonio, Moniche, Francisco et al. DOI: 10.1016/j.ijcha.2022.100977
PMID: 35251309 Journal: Therapeutic Advances in Neurological Disorders Year: 2022 Reference: Ther Adv Neurol Disord. 2022 Mar 2;15:17562864221078177. doi: 10.1177/17562864221078177. eCollection 2022. Impact factor: 6.57 Publication type: Review in international publication Authors: Brehm, Alex, Tsogkas, Ioannis, Ospel, Johanna M, Appenzeller-Herzog, Christian, Aoki, Junya, Kimura, Kazumi, Pfaff, Johannes A R, Mohlenbruch, Markus A, Requena, Manuel, Ribo, Marc J et al. DOI: 10.1177/17562864221078177
PMID: 35238817 Journal: NEUROSURGERY Year: 2022 Reference: Neurosurgery. 2022 Jun 1;90(6):725-733. doi: 10.1227/NEU.0000000000001902. Epub 2022 Mar 7. Impact factor: 4.654 Publication type: Paper in international publication Authors: Nayak, Sanjeev, Jabbour, Pascal, Dmytriw, Adam A, Sweid, Ahmad, Piotin, Michel, Bekelis, Kimon, Sourour, Nader, Raz, Eytan, Linfante, Italo, Dabus, Guilherme et al. DOI: 10.1227/NEU.0000000000001902
PMID: 35055339 Journal: Journal of Personalized Medicine Year: 2022 Reference: J Pers Med. 2022 Jan 1;12(1). pii: jpm12010024. doi: 10.3390/jpm12010024. Impact factor: 4.945 Publication type: Paper in international publication Authors: Raventos, Berta, Molina, Carlos, Ribo, Marc, Almirante, Benito, Len, Oscar, Planas, Bibiana, Torrella, Ariadna, Dallo, Hermes Salvatore, Marquez-Algaba, Ester, Sanchez, Marc et al. DOI: 10.3390/jpm12010024
PMID: 33043545 Journal: EUROPEAN JOURNAL OF NEUROLOGY Year: 2021 Reference: Eur J Neurol. 2021 Feb;28(2):540-547. doi: 10.1111/ene.14579. Epub 2020 Nov 13. Impact factor: 6.089 Publication type: Paper in international publication Authors: Francisco-Pascual, Jaume, Bustamante, Alejandro, Penalba, Anna, Comas, Imma, Rodriguez, Maite, De Lera Alfonso, Mercedes, Arenillas, Juan F, de Torres, Reyes, Perez-Sanchez, Soledad, Cabezas, Juan Antonio et al. DOI: 10.1111/ene.14579
PMID: 33423513 Journal: STROKE Year: 2021 Reference: Stroke. 2021 Jan;52(2):505-510. doi: 10.1161/STROKEAHA.120.032025. Epub 2021 Jan 11. Impact factor: 7.914 Publication type: Paper in international publication Authors: Garcia-Tornel, Alvaro, Deck, Matias, Muchada, Marian, Boned, Sandra, Rodriguez, Noelia, Juega, Jesus, Rodriguez-Luna, David, Pagola, Jorge, Rubiera, Marta, Hernandez-Jimenez, Macarena et al. DOI: 10.1161/STROKEAHA.120.032025
UMBRELLA, a consortium of over 20 public and private partners, kicks off this week with the aim of revolutionising the entire stroke care pathway in Europe by adopting a holistic approach that covers stroke diagnosis, prevention and care.
The Consortium will create a platform to facilitate a personalised management for stroke patients, enabling a more efficient personalized monitoring and patient follow up.
Funding is key to bringing the neuroprotective drug ApTOLL to market and providing a new therapeutic option for the patients.
